secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bioventus Inc. (BVS)
CIK:        0001665988
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0001628280-23-017427
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bioventus delays Q1 10-Q filing; prelim revenue ~$119M, Adj. EBITDA ~$17M
-------------------------------------------------------------------------

- Filing delayed due to complexity in tax structure and noncontrolling equity interest calculation.
- Preliminary Q1 revenue ~$119M; Adjusted EBITDA ~$17M; no impact on revenue or EBITDA from the calculation.
- Company expects to file Form 10-Q by May 16, 2023, and remain in compliance with all financial covenants.
- Earnings call rescheduled to May 16, 2023 at 8:30 a.m. ET.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1665988/000162828023017427/0001628280-23-017427-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1665988/000162828023017427/bvs-20230511.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-017427

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer